Transient ischemia induces massive nuclear accumulation of SUMO2/3-conjugated proteins in spinal cord neurons
1Department of Anesthesiology, Multidisciplinary Neuroprotection Laboratories, Duke University Medical Center, Durham, NC 27710, USA.
Objectives:
The objective of this study is to determine whether transient spinal cord ischemia activates small ubiquitin-like modifier (SUMO1-3) conjugation, a post-translational protein modification that protects neurons from ischemia-like conditions.
Methods:
Mice were subjected to 8-12 min of spinal cord ischemia and 3-24 h of recovery using a newly developed experimental model. To characterize the model, activation of stress response pathways induced after spinal cord ischemia, previously observed in other experimental models, was verified by western blot analysis. Levels and subcellular localization of SUMO-conjugated proteins in spinal cords were evaluated by western blot analysis and immunohistochemistry, respectively.
Results:
Following transient spinal cord ischemia, stress responses were activated as indicated by increased phosphorylation of eukaryotic initiation factor 2 (eIF2α), extracellular signal-regulated kinases (ERK1/2) and Akt. SUMO1 conjugation was not altered, but a selective rise in levels of SUMO2/3-conjugated proteins occurred, peaking at 6 h reperfusion. The marked activation of SUMO2/3 conjugation was a neuronal response to ischemia, as indicated by co-localization with the neuronal marker NeuN, and was associated with nuclear accumulation of SUMO2/3-conjugated proteins.
Conclusion:
Our study suggests that spinal cord neurons respond to ischemic stress by activation of SUMO2/3 conjugation. Many of the identified SUMO target proteins are transcription factors and other nuclear proteins involved in gene expression and genome stability. It is therefore concluded that the post-ischemic activation of SUMO2/3 conjugation may define the fate of neurons exposed to a transient interruption of blood supply, and that this pathway could be a therapeutic target to increase the resistance of spinal cord neurons to transient ischemia.
Insights
Transient spinal cord ischemia activates SUMO2/3 conjugation in neurons, a protective response involving nuclear protein modification. This pathway may enhance neuronal resistance to ischemia and offers a potential therapeutic target.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Transient spinal cord ischemia poses a significant threat to neuronal survival.
- Small ubiquitin-like modifier (SUMO) conjugation is a post-translational modification implicated in cellular protection.
- The role of SUMOylation in neuronal response to spinal cord ischemia is not well understood.
Purpose of the Study:
- To investigate the activation of SUMO1-3 conjugation in response to transient spinal cord ischemia.
- To determine if SUMOylation plays a protective role in neurons under ischemic conditions.
Main Methods:
- A novel experimental model of transient spinal cord ischemia in mice (8-12 min) with varying recovery periods (3-24 h) was utilized.
- Western blot analysis was employed to assess stress pathway activation and SUMO-conjugated protein levels.
- Immunohistochemistry was used to determine the subcellular localization of SUMO-conjugated proteins and their co-localization with neuronal markers.
Main Results:
- Transient spinal cord ischemia activated key stress response pathways, including eIF2α, ERK1/2, and Akt phosphorylation.
- SUMO1 conjugation remained unchanged, while SUMO2/3 conjugation significantly increased, peaking at 6 hours post-ischemia.
- Activated SUMO2/3 conjugation was localized in neuronal nuclei, indicating a specific neuronal response to ischemic stress.
Conclusions:
- Spinal cord neurons activate SUMO2/3 conjugation as a response to ischemic stress.
- SUMO2/3 conjugation targets nuclear proteins, including transcription factors, influencing gene expression and genome stability.
- Post-ischemic SUMO2/3 conjugation activation is a critical factor in neuronal fate determination and represents a potential therapeutic target for enhancing spinal cord neuron resistance to ischemia.
Related Concept Videos
Secondary Spinal Cord Injury llI: Pathophysiology
Nuclear Localization Signals and Import


